Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

about

Drug-induced liver injury: a summary of recent advances.Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats.Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

P2860

Q37867695-29433C7D-B918-41EA-8DCC-46DAECE749F2 Q39638878-835D463B-E6C6-489D-B372-1260A3397951 Q46169240-A3AD964E-26D0-4480-96B6-3C945CCBEF6B

P2860

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

Item

http://www.wikidata.org/entity/Q43080211

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@en

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@nl

type

Item

label

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@en

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@nl

prefLabel

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@en

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@nl

P1476

Xanthine oxidase inhibition by ...... hepatotoxicity in HepG2 cells.

@en

P2093

Alma Tostmann

http://www.w3.org/2001/XMLSchema#string

Martin J Boeree

http://www.w3.org/2001/XMLSchema#string

P N Richard Richard

http://www.w3.org/2001/XMLSchema#string

Rob E Aarnoutse

http://www.w3.org/2001/XMLSchema#string

Wilbert H M Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration

Idiosyncratic drug reactions: the reactive metabolite syndromes.

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.

Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects.

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

Hepatotoxicity of pyrazinamide: cohort and case-control analyses.

High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.

P304

325-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01480540903449715

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43353765

http://www.w3.org/2001/XMLSchema#string

P698

20429806

http://www.w3.org/2001/XMLSchema#string

P921

hepatotoxicity

pyrazinoic acid

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

about

P2860

P2860

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921